logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 3-Trifluoromethoxyaniline CAS 1535-73-5

3-Trifluoromethoxyaniline CAS 1535-73-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1535-73-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Plastic bottles, Plastic buckets

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1535-73-5
Appearance::
Colorless Liquid
Molecular Formula::
C7H6F3NO
Molecular Weight::
177.12400
EINECS NO::
216-256-3
MDL NO::
MFCD00041511
CAS NO::
1535-73-5
Appearance::
Colorless Liquid
Molecular Formula::
C7H6F3NO
Molecular Weight::
177.12400
EINECS NO::
216-256-3
MDL NO::
MFCD00041511
3-Trifluoromethoxyaniline CAS 1535-73-5

Product Description:

Product Name: 3-Trifluoromethoxyaniline CAS NO: 1535-73-5

 

 

Synonyms:

TIMTEC-BB SBB006603;

M-(TRIFLUOROMETHOXY)ANILINE;

BUTTPARK 44�3-14;

 

 

Chemical & Physical Properties:

Appearance: Colorless liquid

Assay :≥99.0%

Density: 1.325

Boiling Point: 72-75℃(8 mmHg)

Flash Point: 85℃

Refractive Index: 1.465-1.467

Stability: Stable under normal temperatures and pressures

Storage Condition: Keep away from sources of ignition. Store in a cool, dry place. Store in a tightly closed container.

Vapor Pressure: 0.41mmHg at 25℃

Water Solubility: Not miscible or difficult to mix in water

 

 

Safety Information:

Symbol: GHS07

Signal Word: Warning

WGK Germany: 3

RIDADR: UN 2810

Hazard Codes: Xn,Xi,T

Hazard Class: 6.1

HS Code: 29222900

Safety Statements: S26-S36/37/39

Risk Statements: R20/21/22; R36/37/38

Hazard Statements: H302-H312-H315-H319-H332-H335

Precautionary Statements: P261-P280-P305 + P351 + P338

 

 

3-(Trifluoromethoxy)aniline is reactant in the synthesis of pyrazolone-quinazolone hybrids as human hydroxyphenylpyruvate dioxygenase inhibitors which is a potential treatment for type I tyrosinemia.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.